Market expansion Pavilion Compounding serves multiple states (GA, SC, NC, TN, KY, NJ, FL) with non-sterile services, indicating potential to expand into additional state markets or deepen penetration in current ones through regional partnerships, medical networks, and long-term contract compounding agreements.

Niche expertise Specialization in bio-identical hormones, pain management, pediatric and veterinary compounding, sleep disorders and nasal ketamine formulations provides entry points for targeted outreach to endocrinology clinics, pain management centers, pediatrics practices, veterinary clinics, and sleep disorder specialists seeking customized therapies.

Innovative formulations Pioneering nasal ketamine for depression and pain, plus SteriPellet bio-identical hormone pellets, highlights a track record of product innovation and differentiation that can be leveraged to partner with clinics and hospitals looking for cutting-edge compounded therapies and exclusive formulations.

Digital and e commerce footprint Active tech stack including WordPress, Shopify, WooCommerce, Mixpanel and analytics tools suggests readiness for direct-to-practice and direct-to-patient channels, enabling scalable marketing, patient education, and subscription or bundled service models.

Financial and scale signals Revenue range of 1M to 10M with a small team implies high potential for strategic partnerships to expand service lines, increase production capacity, and pursue contract manufacturing opportunities with mid-market distributors or clinics seeking reliable compounding partners.